New legislation increases the speed of the FDA approval process for generics by introducing fees for applying manufacturers. This is not a new approach manufacturers have been paying application
The ruling sends a warning to drug makers that try to deter generic rivals from entering the market by settling potential patent claims, paying the competitors to stay out of
